Cellply is developing and bringing to market an unprecedented platform for single live cell analysis and manipulation.
Our goal is to dramatically improve the understanding of cell function during development, production and clinical use of advanced therapeutic products in oncology and beyond.
By combining robotics, microfluidics and AI, our tools enable massive screening of immune and tumor cell interactions and the characterization of live cell response to treatments.